You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families

Article info

Article menu

Download PDFPDF

XML
Research Article
Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families

Authors

  • S. Yado Chemical Engineering and Biotechnology, and Adelson School of MedicineAriel University 40700 Ariel Israel PubMed articlesGoogle scholar articles
  • G. Luboshits Chemical Engineering and Biotechnology, and Adelson School of MedicineAriel University 40700 Ariel Israel Ariel Center for Applied Cancer ResearchAriel University 40700 Ariel Israel PubMed articlesGoogle scholar articles
  • O. Hazan Department of Bone Marrow Transplantation and Cancer ImmunotherapyHadassah-Hebrew University Medical Center Jerusalem Israel PubMed articlesGoogle scholar articles
  • R. Or Department of Bone Marrow Transplantation and Cancer ImmunotherapyHadassah-Hebrew University Medical Center Jerusalem Israel PubMed articlesGoogle scholar articles
  • M. A. Firer Chemical Engineering and Biotechnology, and Adelson School of MedicineAriel University 40700 Ariel Israel Ariel Center for Applied Cancer ResearchAriel University 40700 Ariel Israel Adelson Medical SchoolAriel University 40700 Ariel Israel PubMed articlesGoogle scholar articles

Citation

Yado S, Luboshits G, Hazan O, et al
Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families
Journal for ImmunoTherapy of Cancer 2019;7:301. doi: 10.1186/s40425-019-0776-9
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.